A health conditioning method and system based on meridian and acupoint targeted transdermal administration

Abstract

The application provides a health conditioning method and system based on meridian and acupoint targeted transdermal drug delivery, relates to the technical field of health conditioning, acquires preset key acupoint information, performs key acupoint series analysis according to the preset key acupoint information, acquires acupoint series analysis data, generates a targeted conditioning path according to the acupoint series analysis data, performs synergistic control according to the targeted conditioning path, acquires synergistic control data, performs synergistic action analysis according to the synergistic control data, acquires synergistic action analysis data, performs control adjustment analysis according to the targeted conditioning path in combination with the synergistic action analysis data, acquires control adjustment analysis data, performs health conditioning control adjustment according to the control adjustment analysis data, and acquires health conditioning control adjustment data. The application effectively solves the problems of insufficient traditional conditioning standardization, poor transdermal targeting and no closed-loop optimization, and significantly improves acupoint positioning accuracy and conditioning effect stability.

Description

Technical Field

[0001] This invention proposes a health conditioning method and system based on meridian acupoint targeted transdermal drug delivery, which relates to the field of health conditioning technology, specifically to the field of meridian acupoint targeted transdermal drug delivery for health conditioning. Background Technology

[0002] The combination of meridian acupoint therapy and transdermal drug delivery technology is an important direction in the current health conditioning field. However, existing technologies have many shortcomings, making it difficult to achieve precise, efficient, and standardized conditioning. Traditional meridian acupoint therapy relies on the experience of professionals, lacks quantitative standards, has large deviations in acupoint location, and suffers from chaotic connection sequences, easily leading to problems such as meridian cross-contamination and loss of Qi conduction. Transdermal drug delivery often uses uniform dosages, failing to adapt to the characteristics of different skin sites, and the application and acupoint operation are disconnected, resulting in low transdermal efficiency and significant drug waste. At the same time, existing methods lack anomaly identification and collaborative correction mechanisms, making it impossible to accurately trace the source of anomalies or provide targeted treatment. The conditioning process lacks closed-loop optimization, leading to unstable conditioning effects, insufficient safety, and high dependence on professionals, making it difficult to achieve industrialization and widespread application. Summary of the Invention

[0003] This invention provides a health conditioning method and system based on meridian acupoint targeted transdermal drug delivery to solve the above-mentioned problems: This invention proposes a health conditioning method and system based on meridian acupoint targeted transdermal drug delivery, the method comprising: S1. Obtain preset key acupoint information, perform key acupoint series analysis based on preset key acupoint information, obtain acupoint series analysis data, and generate targeted conditioning path based on the acupoint series analysis data. S2. Perform synergistic control based on the targeted conditioning pathway, obtain synergistic control data, and perform synergistic effect analysis based on the synergistic control data to obtain synergistic effect analysis data; S3. Based on the targeted conditioning pathway and synergistic effect analysis data, control and regulation analysis is performed to obtain control and regulation analysis data. Based on the control and regulation analysis data, health conditioning and control are performed to obtain health conditioning and control data.

[0004] Furthermore, the system includes: The path generation module is used to acquire preset key acupoint information, perform key acupoint chain analysis based on the preset key acupoint information, obtain acupoint chain analysis data, and generate a targeted conditioning path based on the acupoint chain analysis data. The synergistic effect module is used to perform synergistic control based on the targeted conditioning path, obtain synergistic control data, and perform synergistic effect analysis based on the synergistic control data to obtain synergistic effect analysis data. The control and regulation module is used to perform control and regulation analysis based on the targeted conditioning path and synergistic effect analysis data, obtain control and regulation analysis data, and then perform health conditioning control and regulation based on the control and regulation analysis data to obtain health conditioning control and regulation data.

[0005] The beneficial effects of this invention are as follows: This method solves the pain points of traditional conditioning methods, such as lack of standards, poor transdermal targeting, and lack of closed-loop optimization; it improves the accuracy of acupoint positioning, the stability of conditioning, and the level of standardization, reducing the dependence on professional personnel; it reduces the probability of ineffective conditioning, the risk of skin irritation, and human error, and reduces the difficulty of technical implementation; at the same time, it enables the conditioning process to be traceable and reproducible, further enhancing the industrial application value of the technology.

[0006] Traditional Chinese medicine (TCM) meridian theory holds that the eyes are the orifice of the liver, and the nose is the orifice of the lungs; the eyes and nose are interconnected, and their meridian energy influences each other. Multiple meridians are distributed around the eyes; stimulating specific acupoints can harmonize qi and blood, nourishing the eyes. The Yingxiang acupoint on the side of the nose is the terminus of the Large Intestine Meridian of Hand Yangming, and has the function of clearing the lungs and opening the orifices, directly relieving symptoms such as nasal congestion and rhinitis. Furthermore, the Fengchi acupoint at the back of the neck belongs to the Gallbladder Meridian of Foot Shaoyang and is a meeting point of the Yangwei Meridian, which can dispel wind and heat, unblock the meridians, and relieve pain. The Dazhui acupoint is the meeting point of the Governing Vessel and various Yang meridians, governing the body's Yang energy; stimulating these two acupoints can regulate overall nerve tension and relieve stress. The Taiyang acupoint is an extra meridian point; combined with the Yifeng acupoint behind the ear and the pericardium meridian pathway around the ear, it can relax the nerves around the ear and relieve head tension. Therefore, systematically connecting the acupoints around the eyes, the orifice-opening acupoints on the side of the nose, and the spirit-regulating acupoints at the back of the neck to form an integrated head-face-back neck conditioning pathway has significant clinical value.

[0007] After reviewing relevant literature, the *Compendium of Materia Medica* records formulas for brightening the eyes and clearing the orifices on the face. Li Shizhen emphasized that the meridians are the pathways through which treatments are applied, and that applying aromatic orifice-opening herbs along the meridians can help the medicine reach the affected area directly. Hua Tuo, in the *Zhongzang Jing*, recorded methods of external treatment where the medicinal qi enters the skin and travels along the meridians, emphasizing that external medications must be combined with acupoint stimulation to be effective. Sun Simiao's *Qianjin Fang* also contains several external facial formulas, emphasizing the principle of using acupoints to guide the medicine and using medicine to clear the meridians. This solution, based on the external formulas recorded in the above-mentioned classical medical books, combines modern transdermal drug delivery technology, using a sustained-release pen as a carrier, to innovatively integrate the classic formula concepts with acupoint-targeted transdermal delivery systems, achieving the effect of using ancient methods in modern times and synergistic effects of acupoints and medicine. Attached Figure Description

[0008] Figure 1 This is a schematic diagram of a health conditioning method based on meridian acupoint targeted transdermal drug delivery. Figure 2 This is a diagram illustrating meridian massage. Detailed Implementation

[0009] The preferred embodiments of the present invention will be described below with reference to the accompanying drawings. It should be understood that the preferred embodiments described herein are for illustration and explanation only and are not intended to limit the present invention.

[0010] In one embodiment of the present invention, a health conditioning method and system based on meridian acupoint targeted transdermal drug delivery is proposed, the method comprising: S1. Obtain preset key acupoint information, perform key acupoint series analysis based on preset key acupoint information, obtain acupoint series analysis data, and generate targeted conditioning path based on the acupoint series analysis data. The key acupoints in the preset facial acupoint information are, in order: Jingming, Zanzhu, Yuyao, Sizhukong, Taiyang, Tongziliao, Chengqi, and Sibai. These eight acupoints are the main meridians around the eyes. Pressing them in sequence can unblock the Qi of the Bladder Meridian of Foot Taiyang, the Gallbladder Meridian of Foot Shaoyang, the Stomach Meridian of Foot Yangming, and the Triple Energizer Meridian of Hand Shaoyang, thus nourishing the eyes and unblocking the meridians around the eyes. The acupoint information on both sides of the nose is Yingxiang. Pressing this acupoint first can open the nasal passages and promote lung Qi, laying the foundation for subsequent acupoint treatment around the eyes. The acupoint information around the ears includes Yifeng and the pericardium meridian area behind the ear, which can soothe the nerves around the ears and regulate the Qi of the pericardium meridian to help calm the mind. The acupoint information on the back of the neck includes Fengchi and Dazhui. Fengchi can dispel wind and unblock the meridians and regulate the tension of the nerves in the head, while Dazhui can govern all Yang meridians and regulate pressure and blood circulation as a whole.

[0011] The above-mentioned acupoint-based treatment pathway is constructed based on the following: Eight major acupoints around the eyes (Jingming, Zanzhu, Yuyao, Sizhukong, Taiyang, Tongziliao, Chengqi, Sibai) are distributed in a ring around the eyes. Applying and pressing these points sequentially allows the medicinal properties to circulate with the Qi and blood, acting on the Bladder Meridian of Foot Taiyang (Jingming, Zanzhu), the Gallbladder Meridian of Foot Shaoyang (Yuyao, Sizhukong, Tongziliao), the Stomach Meridian of Foot Yangming (Chengqi, Sibai), and the extra acupoint Taiyang, achieving full coverage of the meridians around the eyes. This effectively improves blood circulation in the eyes, relieves eye fatigue, and alleviates muscle tension around the eyes. The Yingxiang acupoint is used first to open the orifices and promote circulation. The Lung Meridian and Large Intestine Meridian are internally and externally related. When the nasal passages are clear, the Qi around the eyes also flows smoothly, reflecting the holistic view of "clear nasal and eye passages". Fengchi (GB20) is the meeting point of the Yang Wei Meridian. Stimulation of this point can regulate the vasomotor function and nerve excitability of the head, relieving cervicogenic headaches and tension. Dazhui (GV14) is the meeting point of all Yang meridians. Stimulation of this point can regulate the autonomic nervous system as a whole, reduce sympathetic nerve tension, and achieve the effect of whole-body relaxation. Stimulation of Yifeng (TE17) and the pericardium meridian area behind the ear can calm the mind and relieve anxiety. Together with the above acupoints, they form a full-chain relaxation and conditioning system "from face to neck, from outside to inside".

[0012] S2. Perform synergistic control based on the targeted conditioning pathway, obtain synergistic control data, and perform synergistic effect analysis based on the synergistic control data to obtain synergistic effect analysis data; S3. Based on the targeted conditioning pathway and synergistic effect analysis data, conduct control and regulation analysis to obtain control and regulation analysis data. Then, based on this data, perform health conditioning and control regulation to obtain health conditioning and control regulation data, such as... Figure 1 As shown.

[0013] The instructions for using the meridian massage described above include: Gently massage in circular motions in numerical order, holding each area for 8–10 seconds.

[0014] Recommended acupoints 1-10 for gradual progression: The Dicang acupoint is located in the depression on the outer side of the corner of the mouth, and it can relieve facial tension. Yingxiang acupoint is located in the depression on both sides of the nose, and it helps to unblock the flow of Qi around the nose. The Jingming acupoint is located in the depression at the inner corner of the eye and on the bridge of the nose, and it can relieve soreness and swelling in the inner corner of the eye. The Zanzhu acupoint is located in the depression on the inner side of the eyebrow, and it can relieve the heaviness of the eyebrow. The Yuyao acupoint is located in the middle of the eyebrow; relax your upper eyelid. The Sizhukong acupoint is a depression at the end of the eyebrow tail, which can relieve stiffness at the eyebrow tail. The Tongziliao acupoint is located at the outer corner of the eye, along the edge of the eye socket, and relieves eye fatigue at the outer corner of the eye. The temples are the depressions behind the eyebrows; expanding the area helps relieve pressure on the head. Chengqi acupoint is located at the edge of the lower eye socket; relax the skin around the lower eyelid. The Sibai acupoint is located in the depression above the cheekbone and can improve soreness and swelling around the eyes. The acupoints can be expanded to 11-13: The Yifeng acupoint is located in the depression behind the earlobe and can relieve tension in the head. The Fengchi acupoint is located in the depression on the outer side of the large tendons on both sides of the back of the neck. Relax your head and neck. The Fengfu acupoint is located in the depression at the center of the occipital bone at the back of the neck, and it can improve eye strain and dizziness.

[0015] The preset key acupoint information includes eight acupoints around the eyes, Yingxiang acupoints on both sides of the nose, Yifeng acupoint behind the ear and pericardium meridian area around the ear, Fengchi acupoint and Dazhui acupoint at the back of the neck; among them, the eight acupoints around the eyes are Jingming, Zanzhu, Yuyao, Sizhukong, Taiyang, Tongziliao, Chengqi and Sibai.

[0016] The acupoint sequence of the targeted conditioning pathway is as follows: first, open the acupoint Yingxiang to clear the orifices, then apply and press the acupoints Jingming, Zanzhu, Yuyao, Sizhukong, Taiyang, Tongziliao, Chengqi, and Sibai in sequence, then relax the acupoint Yifeng behind the ear and the pericardium meridian area, and finally finish with the acupoints Fengchi and Dazhui, forming a step-by-step conditioning pathway of "opening the orifices, brightening the eyes, calming the mind, and regulating yang".

[0017] This massage pathway follows the profound principles of meridians in ancient medical texts. It begins around the eyes, ascends to the head, descends along the neck, extends to the shoulders and arms, reaches the palms and fingers, and finally connects to the waist, spine, knees, and feet. This method uses points to connect lines, linking the eyes, head, neck, hands, and feet together.

[0018] All data in this invention are for illustrative purposes only.

[0019] All the key acupoints involved in this invention (Jingming, Zanzhu, Yuyao, Sizhukong, Tongziliao, Chengqi, Sibai, Yingxiang, Ermen, Tinggong, Tinghui, Yifeng, Fengchi, and Fengfu) are clearly recorded in the classic Chinese medicine books *Huangdi Neijing·Lingshu·Jingmai* and *Zhenjiu Dacheng*. *Huangdi Neijing·Lingshu·Jingmai*, as the foundational work of TCM meridian and acupoint theory, clearly records the meridian affiliation, location, and basic functions of each acupoint. For example, Jingming belongs to the Bladder Meridian of Foot Taiyang, Yingxiang belongs to the Large Intestine Meridian of Hand Yangming, and Fengchi belongs to the Gallbladder Meridian of Foot Shaoyang. *Zhenjiu Dacheng* (written by Yang Jizhou of the Ming Dynasty) further refines the location methods, operational procedures, and compatibility applications of each acupoint.

[0020] In this invention, the location of all acupoints is strictly performed in accordance with the standards recorded in *The Great Compendium of Acupuncture and Moxibustion* and *The Yellow Emperor's Inner Classic: Spiritual Pivot - Bone Measurement*. *The Yellow Emperor's Inner Classic: Spiritual Pivot - Bone Measurement* clearly defines the length and proportion of bones in various parts of the human body, providing a precise anatomical reference for acupoint location and avoiding positioning errors. *The Great Compendium of Acupuncture and Moxibustion*, based on this, combines clinical practice to clarify the specific location methods for each acupoint (e.g., Jingming acupoint, located in the depression slightly above the inner canthus of the eye; Fengchi acupoint, located in the depression below the occipital bone in the posterior neck region, between the upper ends of the sternocleidomastoid and trapezius muscles), ensuring the standardization and repeatability of acupoint location in this invention, and solving the problem of the lack of unified standards and reliance on experience in existing technologies for acupoint location.

[0021] The targeted conditioning pathway design and acupoint connection logic of this invention are based on the traditional Chinese medicine meridian theory recorded in the "Huangdi Neijing·Lingshu·Jingmai". This ancient book clearly states that the meridians are the means to determine life and death, treat all diseases, and regulate deficiency and excess, and must not be blocked. It establishes the core role of the meridians as the channel for the circulation of qi and blood and the connection between the internal organs and the body surface, ensuring that the connection of acupoints conforms to the qi and blood transmission law of the meridians, and achieves the conditioning goal of unblocking the meridians and harmonizing qi and blood.

[0022] The core of the big data processing underlying logic of this invention is to achieve dynamic optimization of the acupoint connection sequence and operation parameters through multi-dimensional data collection, standardized data processing, and intelligent modeling and analysis, thereby ensuring the stability and personalized adaptation of the conditioning effect.

[0023] The specific process is as follows: Through the system's supporting positioning components, skin detection module, and user feedback collection module, core data from multiple users (sample size ≥ 1000 cases) can be collected in batches, including acupoint positioning accuracy data, skin characteristic data of different parts (such as thickness, moisture content, and barrier function), operation parameter data during the treatment process (such as application speed, pressure, and release amount), and treatment feedback data (such as physical comfort and symptom relief). The collected raw data is preprocessed through data cleaning (removing abnormal and missing data), data denoising (filtering invalid data caused by environmental interference and operational errors), and data standardization (unifying the quantification standards of data from different dimensions) to obtain clean, standardized, and effective data. By using feature extraction algorithms (such as principal component analysis), core features in the data (such as the correlation between skin thickness and application dosage, and the correlation between acupoint positioning deviation and treatment effect) are extracted. Cluster analysis (classifying users according to skin characteristics and treatment needs) and regression modeling (constructing a correlation model between operation parameters and treatment effects) are used. Through iterative optimization of the model, the optimal acupoint connection sequence, application parameters (release amount, speed), and acupressure parameters (intensity, duration) are output to ensure that each set of operation parameters can be adapted to the individual differences of different users and improve the stability of treatment effects.

[0024] Based on the multi-user treatment data collected using the aforementioned core logic, a time-series optimization model is further constructed. By analyzing the treatment effect data (such as transdermal absorption rate and symptom relief rate) under different series sequences, the optimal series sequence is derived through modeling. The series sequence described in this invention is determined to be the optimal solution, which can minimize the loss of Qi conduction and improve the synergistic treatment effect of multiple acupoints. At the same time, the model can iterate in real time based on new user data to continuously optimize the series sequence, ensuring the adaptability and advancement of the technical solution.

[0025] The active ingredient composition used in this invention strictly adheres to the principles of traditional Chinese medicine, syndrome differentiation and treatment, and addressing both the root cause and symptoms. Based on the core principles of promoting blood circulation, removing blood stasis, nourishing and improving eyesight, and clearing the meridians, it combines the targeted therapeutic pathways (around the eyes, nose, ears, and back of the neck) and acupoints to create a specific formula. Acupoints around the eyes primarily improve eyesight and regulate the internal organs; acupoints around the nose primarily clear the orifices and promote lung function; acupoints around the ears primarily improve hearing and regulate qi and blood; and acupoints at the back of the neck primarily dispel wind and dredge the meridians. Therefore, the formula must balance the three major effects of nourishing and improving eyesight, clearing the meridians, and promoting blood circulation, while also meeting the needs of transdermal drug delivery, considering the transdermal efficiency and skin safety of the active ingredients. This aligns with the effects of clearing the meridians and improving eyesight, and harmonizing qi and blood recorded in the *Huangdi Neijing·Lingshu·Jingmai*, achieving a deep integration of medicinal power and acupoint efficacy, thus enhancing the therapeutic effect.

[0026] The core Chinese herbal components include: Panax notoginseng saponins, which invigorate blood circulation, remove blood stasis, unblock meridians, and relieve pain; Tanshinone, which invigorates blood circulation, removes blood stasis, cools blood, and reduces swelling; Lycium barbarum polysaccharides, which nourish the liver and kidneys, improve eyesight, and moisturize dryness; targeted nourishment of the periorbital tissues; relief of eye fatigue; cassia seed extract, which clears the liver, improves eyesight, and promotes bowel movements; further enhancing the nourishing and vision-improving effects and assisting in regulating organ function; peppermint extract, which disperses wind-heat and clears the head and eyes; relieves headaches and dizziness; suitable for the wind-dispelling effects of acupoints on the back of the neck; and has a slight cooling sensation, enhancing user comfort; and Ligusticum chuanxiong extract, which invigorates blood circulation, promotes qi circulation, dispels wind, and relieves pain; unblocks the meridians of the head and strengthens the conduction of qi; suitable for the conditioning needs of acupoints on the back of the neck and around the ears.

[0027] Azone, as a highly effective transdermal penetration enhancer, can reduce skin barrier resistance, promote the transdermal absorption of the aforementioned active ingredients of traditional Chinese medicine, and improve the transdermal absorption rate, thus solving the problems of difficult transdermal absorption and low absorption efficiency of traditional Chinese medicine ingredients. Glycerin, as a moisturizing and soothing component, can moisturize the skin, repair the skin barrier, reduce the irritation of the transdermal penetration enhancer and traditional Chinese medicine ingredients to the skin, and improve the safety of use. Deionized water, as a solvent, can make all components dissolve evenly, ensuring the uniformity of the sustained-release pen application and ensuring the precise dosage of active ingredients for each acupoint.

[0028] The various Chinese herbal components work synergistically to promote blood circulation, remove blood stasis, nourish and improve eyesight, and unblock meridians, echoing the therapeutic effects of acupoints to achieve a synergistic enhancement of the medicinal power and acupoint efficacy. The transdermal penetration enhancer works synergistically with the Chinese herbal components to improve the transdermal efficiency of active ingredients. The moisturizing component works synergistically with other components to improve skin safety, ultimately achieving a comprehensive therapeutic effect of clearing meridians, harmonizing qi and blood, clearing the head and eyes, and refreshing the mind, while avoiding the problems of insufficient efficacy and obvious side effects of single components.

[0029] The improvement data of the indicators in this invention are all derived from multiple clinical trials (sample size ≥ 500 cases, aged 18-65 years, covering users with different skin types and different conditioning needs). The experimental period is 28 days (one complete skin metabolism and meridian conditioning cycle), with one treatment per day, each treatment lasting 15-20 minutes, strictly following the methods and system described in this invention. After the experiment, data on various indicators were collected using professional testing instruments and user feedback questionnaires, as detailed below: After 28 days of continuous treatment, the eye fatigue relief rate was ≥82% (testing method: using a visual fatigue rating scale, comparing the scores of users' symptoms such as dry eyes, eye irritation, and blurred vision before and after treatment to calculate the relief rate); the nasal congestion improvement rate was ≥78% (testing method: using a nasal ventilation tester, comparing the nasal ventilation volume before and after treatment, combined with user feedback on nasal congestion symptoms to calculate the improvement rate); the tinnitus relief rate was ≥75% (testing method: using a hearing tester, comparing the frequency and loudness of tinnitus before and after treatment, combined with user feedback to calculate the relief rate); and the headache relief rate was ≥80% (testing method: using a visual analog scale for headaches, comparing the headache severity scores before and after treatment to calculate the relief rate).

[0030] The transdermal absorption rate of active ingredients is increased by 35%-45% compared to the single application method (detection method: using the Franz diffusion cell method, the transdermal amount of active ingredients was detected in the single application of serum and the combined application and tapping methods of this invention, and the difference in absorption rate and the increase ratio were calculated). This data shows that the combined application and tapping methods of this invention can effectively promote the transdermal absorption of active ingredients, improve the utilization rate of the drug, and solve the problem of low transdermal efficiency of single application.

[0031] During and after the experiment, no obvious adverse reactions such as skin irritation or allergies were observed in any of the participating samples (detection method: observe and record the skin reactions of users during the treatment process, such as redness, swelling, itching, stinging, etc., and count the incidence of adverse reactions). The incidence of adverse reactions was 0, indicating that the traditional Chinese medicine formula and operation method of the present invention are highly safe, suitable for users with different skin types, and can be used for a long time. At the same time, the treatment effect is stable and reproducible. The deviation of the indicator improvement data in repeated experiments (3 times) is ≤5%, ensuring the reliability and repeatability of the technical solution.

[0032] The working principle and technical effects of the above-mentioned technical solution are as follows: This method achieves targeted and precise conditioning by accurately connecting acupoints, synergistically controlling drug delivery, and dynamically adjusting parameters, breaking through the bottlenecks of traditional conditioning based on experience and non-targeted transdermal drug delivery. In specific implementation, the information of preset key acupoints (including coordinates, meridian affiliation, etc.) is first entered into the system. Based on the meridian and qi conduction law, the rationality of acupoint connection is analyzed, the optimal connection sequence and connection interval are calculated, and acupoint connection analysis data is generated and integrated into a targeted conditioning path. Then, the sustained-release pen, positioning component and other devices are controlled to synergistically perform acupoint application and acupressure operations, and the application dosage, acupressure intensity and other synergistic control data are collected in real time. Then, combined with transdermal effect and somatosensory feedback analysis data, it is judged whether the synergistic effect meets the standard, and synergistic effect analysis data is generated. Finally, the target path is compared with the preset standard, the operation deviation is analyzed, the adjustment direction and amplitude are determined, the operation parameters and material usage are dynamically adjusted, health conditioning control and adjustment data are generated and fed back to the previous stage to form a closed-loop optimization.

[0033] This method addresses the pain points of traditional treatments, such as lack of standards, poor transdermal targeting, and lack of closed-loop optimization; it improves the accuracy of acupoint positioning, the stability of treatment, and the level of standardization, reducing reliance on professionals; it reduces the probability of ineffective treatment, the risk of skin irritation, and human error, and lowers the difficulty of technical implementation; at the same time, it enables the treatment process to be traceable and reproducible, further enhancing the industrial application value of the technology.

[0034] In one embodiment of the present invention, S1 includes: Acquire preset facial acupoint information, acupoint information on both sides of the nose, acupoint information around the ears, and acupoint information at the back of the neck; Based on preset facial acupoint information, acupoint information on both sides of the nose, acupoint information around the ears, and acupoint information at the back of the neck, determine the information along the facial meridians, the information along the meridians on both sides of the nose, the information along the meridians around the ears, and the information along the acupoints at the back of the neck. A preset active ingredient composition and a sustained-release pen are obtained. The preset active ingredient composition is stored and quantitatively released through the sustained-release pen to obtain sustained-release pen application data. According to the preset sequence of connection, the information along the facial meridians, the information along the meridians on both sides of the nose, the information along the meridians around the ears, and the information along the acupoints at the back of the neck are connected to obtain acupoint connection data. By using acupoint data to perform coordinated application of the slow-release pen, coordinated application data is obtained. Targeted treatment pathways were determined based on data from synergistic application.

[0035] The working principle and technical effects of the above technical solution are as follows: This method is based on the principles of precise acquisition of acupoint and meridian information, device collaboration, serial application, and path optimization. By accurately acquiring acupoint and meridian information from multiple locations, combined with the quantitative release function of the sustained-release pen, it ensures the accuracy of acupoint serialization and the rationality of application, providing a reliable targeted path. In specific implementation, firstly, the preset acupoint information for the face, sides of the nose, periauricular region, and back of the neck is acquired. Combined with the meridians to which each acupoint belongs, the effective action zone information along the meridians of each location is accurately determined. Then, a preset active ingredient composition and a sustained-release pen are prepared. The sustained-release pen is adjusted to ensure that it can quantitatively release materials, and application data such as release amount and release speed are collected. Subsequently, according to the preset order and combined with the direction of meridian qi conduction, acupoints along the meridians of the face, nose, and other locations are serialized to obtain serialized data including serialization order and acupoint coordinates. Based on this serialized data, the sustained-release pen is controlled to apply along the serialized path, and application data such as application coverage and connection sequence are collected. Finally, combined with the application data, the path details are optimized to determine the final targeted conditioning path.

[0036] This method addresses the problems of inaccurate matching of acupoints and meridians, lack of basis for connection, and disconnect between application and acupoints in existing technologies; it improves the accuracy of positioning along meridians and the rationality of connection, ensuring the reliability of the target path; it reduces the risk of ineffective treatment due to mismatch of acupoints and meridians, and improves the effectiveness of subsequent synergistic control; at the same time, it optimizes the adaptability of the target path, providing a basis for personalized treatment for users with different constitutions.

[0037] In one embodiment of the present invention, the step of connecting facial meridian information, meridian information on both sides of the nose, meridian information around the ear, and acupoint information at the back of the neck according to a preset serial sequence to obtain acupoint serialization data includes: Obtain acupoint location information, and determine the acupoint location information along the acupoint line based on the acupoint line information and the acupoint location information; Set a threshold for acupoint location deviation (≤3mm is normal, 3-5mm is slight deviation, ≥5mm is severe deviation), supplement the quantitative threshold for location deviation, and solve the problem of no standard; The location information of acupoints along the line is connected according to a preset connection sequence to obtain the location connection information; The acupoint location information is linked along the line according to the preset linkage sequence (from the face to both sides of the nose to the ear area to the back of the neck), and the connection interval between adjacent acupoints is controlled to be 0.5 and 1 second to obtain the location linkage information; the specific content of the linkage sequence and the connection interval are clarified to solve the problem of time sequence disorder. Perform location anomaly identification on the location serialization information to obtain location anomaly identification information; By comparing the actual location of acupoints with preset coordinates, slight deviations, severe deviations, and deviations along the meridian are identified, and location anomaly identification information is obtained. Based on the location anomaly identification information, determine the acupoint-related anomaly identification information; distinguish between location deviation anomalies and meridian matching anomalies; Matching and determining information is performed based on abnormal identification information along the acupoints; Determine the level of abnormality and the scope of its impact; The acupoint location is corrected based on the matching judgment information until there is no abnormal location identification information, and acupoint serialization data is generated.

[0038] Positioning correction (minor deviations are corrected by coordinate fine-tuning, and severe deviations are repositioned and calibrated), the acupoint connection data includes positioning coordinates, connection sequence, connection interval, meridian matching degree, etc., and this data is synchronized to the collaborative application process.

[0039] The working principle and technical effect of the above technical solution are as follows: The principle of this method is to set a positioning deviation threshold, standardize the serial timing, and combine anomaly identification and hierarchical correction to achieve the accuracy and standardization of acupoint serialization, solve the problems of no standard serial positioning, chaotic timing, and ineffective anomaly correction, and ensure the reliability of serial data. In practice, the actual location information of acupoints is first obtained through the positioning component, and combined with the preset meridian information to determine the positioning information along the meridian. Acupoint positioning deviation thresholds are set (≤3mm is normal, 3-5mm is slight deviation, and ≥5mm is severe deviation). The meridians are connected in sequence from the face to the nose to the ear to the back of the neck, and the connection interval between adjacent acupoints is controlled at 0.5-1s to avoid the interruption of meridian qi transmission. The actual positioning of acupoints is compared with the preset coordinates to identify slight / severe positioning deviations and abnormalities of deviating from the meridian action zone, and to distinguish between positioning deviation abnormalities and meridian matching abnormalities. The abnormality level and the scope of influence are determined. For slight deviations, coordinate fine-tuning is used, and for severe deviations, repositioning and calibration are performed until there are no abnormalities. Finally, acupoint connection data containing positioning coordinates, connection sequence, connection interval, and meridian matching degree is generated and synchronized to the subsequent collaborative application stage to ensure accurate matching between application and connection.

[0040] This method addresses the pain points of existing acupoint connection methods, such as lack of quantitative standards, chaotic timing, and lack of basis for abnormal correction; it improves the accuracy and timing stability of acupoint connection, avoids meridian cross-connection, reduces the risk of application failure due to positioning deviation, and reduces the loss of meridian energy transmission, further enhancing the overall effect of multi-acupoint synergistic conditioning.

[0041] In one embodiment of the present invention, the step of obtaining coordinated application data by using acupoint serial data for the coordinated application of a sustained-release pen includes: Serial feature extraction is performed on the serial acupoint data to obtain serial feature extracted data; Extract the location coordinates, sequential timing, connection intervals, and distribution characteristics along the meridian of acupoints; Preliminary smearing parameters are generated by extracting data based on concatenated features. Based on the data extracted from the tandem features, preliminary application parameters were generated by combining the skin characteristics of different parts of the body (single release volume of 0.1 and 0.2 ml / acupoint for facial / periauricular acupoints, 0.1 ml / acupoint for acupoints on both sides of the nose, and 0.2 and 0.3 ml / acupoint for acupoints on the back of the neck; application speed of 1 and 2 cm / s), thus obtaining the preliminary application parameters; Based on the initial application parameters, perform acupressure massage to obtain acupressure massage data; Apply pressure and massage based on the initial application parameters. Control the pressure to a slight soreness or distension in the user. Apply pressure for 5 or 15 seconds and obtain pressure and massage data (including pressure, duration, and body feedback). By integrating the initial application parameters with the acupressure massage data, synergistic application data is obtained.

[0042] By integrating the initial application parameters with the acupressure massage data, the application parameters are optimized (the release amount of the slow-release pen is appropriately increased when the acupressure force is insufficient, and the acupressure force is reduced and the application speed is finely adjusted when the body feels uncomfortable), generating optimized application parameters. Combined with the release amount uniformity and coverage data during the application process, complete collaborative application data is obtained.

[0043] The working principle and technical effect of the above technical solution are as follows: The core principle of this method is to combine the characteristics of acupoint connection with the physiological differences of skin in different parts, set differentiated application parameters, integrate acupressure massage data to optimize the application plan, and achieve synergistic penetration promotion of application and acupressure, thus solving the problems of single application parameters, disconnect between acupressure and application, and low transdermal efficiency in existing technologies. In practice, the acupoint series data is first extracted to accurately obtain the acupoint location coordinates, series sequence, connection interval, and distribution characteristics along the meridian, providing a basis for setting application parameters. Considering the physiological differences in the thin skin of the face and periauricular region and the thick skin of the back of the neck, differentiated preliminary application parameters are set (0.1 and 0.2 ml / acupoint for the face / periauricular region, 0.1 ml / acupoint for both sides of the nose, and 0.2 and 0.3 ml / acupoint for the back of the neck; application speed 1 and 2 cm / s). The slow-release pen is applied according to these parameters, while acupressure massage is performed simultaneously. The pressure is controlled to a level that causes slight soreness in the user, with a massage time of 5 and 15 seconds. Real-time data on pressure, duration, and user feedback are collected. The preliminary application parameters and massage data are integrated to optimize the application plan (increasing the release amount appropriately when the pressure is insufficient, reducing the pressure and fine-tuning the speed when discomfort is felt). Then, data on the uniformity of release and acupoint coverage during the application process are collected to obtain complete collaborative application data.

[0044] This method addresses the shortcomings of existing topical application methods, such as inconsistent dosage, lack of synergy between application and dabbing, and low transdermal efficiency. It improves transdermal absorption efficiency and application uniformity, reducing facial skin irritation and insufficient post-treatment drug absorption. It also reduces drug waste, enhances the targeting and therapeutic effect of synergistic application, and adapts to the skin characteristics of different areas, further improving user comfort and the safety of treatment.

[0045] In one embodiment of the present invention, S2 includes: Material control parameters are determined by targeting the conditioning path, and application control data is obtained by applying the material control parameters to the targeted conditioning path. Material control parameters include slow-release pen release volume, application speed, and dotting standards; Based on the application control data, an application control analysis is performed to obtain application control analysis data; Based on the smear control analysis data, abnormal control characteristics are determined, and abnormal control characteristic data are obtained. Based on the abnormal control characteristic data, collaborative control analysis is performed to obtain collaborative control analysis data; Based on the collaborative control analysis data, collaborative control is performed to obtain collaborative effect data; The status of the synergistic effect data is determined to obtain synergistic effect analysis data.

[0046] Example of condition judgment criteria: Synergistic effect meets the standard: transdermal rate ≥ 70% of the theoretical rate of a single acupoint, and there is no obvious data on physical discomfort.

[0047] The working principle and technical effects of the above-mentioned technical solution are as follows: The principle of this method is based on the precise control of material parameters through targeted conditioning pathways. By controlling the application, identifying abnormalities, conducting synergistic analysis, and determining the effects, it achieves standardized synergistic control of the transdermal drug delivery process, solving the problems of existing technologies such as lack of standards for synergistic control, inability to quantify effects, and inability to trace the source of abnormalities. In specific implementation, firstly, based on the targeted conditioning pathway and the application requirements of each acupoint, the material control parameters (including the release amount of the sustained-release pen, application speed, and acupressure standards) are determined, and the equipment is debugged to ensure accurate parameter execution; the application of the targeted conditioning pathway is controlled according to the set parameters, and application control data such as the actual release amount of the sustained-release pen, application speed, and acupressure pressure are collected in real time; the application control data is analyzed to identify parameter execution deviations, determine abnormal control characteristics, and generate abnormal control characteristic data; synergistic control analysis is conducted on the abnormal data to clarify the abnormal impact and correlation, and generate synergistic control analysis data; the collaborative working state of the equipment is adjusted according to this data, and synergistic effect data is collected; finally, the synergistic effect data is judged according to the preset standards (transdermal rate ≥ 70% of the theoretical rate of a single acupoint, no obvious physical discomfort), and synergistic effect analysis data is generated to provide a basis for subsequent adjustments.

[0048] This method addresses the pain points of existing collaborative control methods, such as lack of standards, inability to quantify effects, and inability to trace anomalies; it improves the accuracy and stability of collaborative control, clarifies the achievement of synergistic effects, reduces the risk of poor treatment results due to loss of control over synergy, and enables the quantitative determination of synergistic effects, further enhancing the standardization and controllability of the treatment process.

[0049] In one embodiment of the present invention, the step of performing application control analysis based on application control data to obtain application control analysis data includes: Preliminary application parameters and actual application parameters are obtained based on the application control data; Actual application parameters include the actual release amount of the slow-release pen, application speed, and tapping data; The preliminary application parameters are compared with the actual application parameters to obtain application comparison parameters; Compare and calculate the deviation values ​​of the parameters (a deviation of ≤ ±0.05ml / acupoint is normal, and a deviation of ≤ ±0.3cm / s is normal) to obtain the application comparison parameters; Based on the smearing comparison parameters, determine the smearing anomaly characteristics and obtain smearing anomaly characteristic data; Abnormal features are used to distinguish between abnormal parameter deviations, abnormal operating techniques, and abnormal slow-release pen malfunctions, thereby obtaining abnormal application feature data. Based on the abnormal smearing feature data, the abnormal smearing control data is determined, and then the smearing control analysis data is obtained.

[0050] The abnormal control data of the smearing (including the cause of the abnormality and the scope of the impact) will be synchronized to the collaborative control analysis stage to obtain complete smearing control analysis data.

[0051] The working principle and technical effect of the above technical solution are as follows: The principle of this method is to accurately identify the type and cause of application abnormalities by comparing the preliminary application parameters with the actual application parameters and setting a quantitative deviation threshold. This enables precise tracing and targeted control of application abnormalities, solving the problems of ambiguous identification, inability to trace the source, and lack of targeted treatment in existing technologies. In specific implementation, preliminary application parameters (optimized) and actual application parameters are first extracted from the application control data. The actual parameters include the actual release amount of the slow-release pen, application speed, and tapping data. The two sets of parameters are compared, the parameter deviation value is calculated, and a deviation threshold is set (release amount deviation ≤ ±0.05ml / acupoint is normal, and application speed deviation ≤ ±0.3cm / s is normal) to obtain application comparison parameters. Based on the comparison parameters, three types of abnormalities are distinguished: abnormal parameter deviation, abnormal operation technique, and abnormal slow-release pen malfunction. The characteristics of application abnormalities are determined, and application abnormality characteristic data is generated. The causes and scope of influence of the abnormalities are further analyzed to generate application abnormality control data containing the causes and scope of influence. After integration, complete application control analysis data is obtained and synchronized to the subsequent collaborative control analysis stage.

[0052] This method addresses the pain points of existing treatments, such as vague identification of abnormalities, inability to trace their origin, and lack of targeted treatment. It improves the accuracy of abnormality identification and the targeted nature of treatment, reducing the impact of abnormalities on the therapeutic effect. It also reduces the risk of transdermal failure and skin irritation caused by improper handling of abnormalities. At the same time, it enables precise traceability of abnormalities, providing direction for equipment maintenance and operation optimization, and improving the overall stability of the system.

[0053] In one embodiment of the present invention, the step of performing collaborative control analysis based on abnormal control feature data to obtain collaborative control analysis data includes: The anomaly control feature data is parsed to obtain anomaly control parsing data; Anomaly control analysis data includes anomaly type, anomaly level (minor / serious), and location of occurrence; Determine the impact data of abnormal control based on the abnormal control analysis data; Based on the abnormal control analysis data, the impact data of abnormal control is determined, and the degree of impact of abnormality on transdermal effect, transgas conduction, and user sensation is analyzed. Correlate the abnormal control analysis data with the abnormal control impact data to obtain abnormal control correlation data; The anomaly control association data is used to identify the derived relationships between anomalies (such as positioning deviation causing smearing anomalies). Based on the abnormal control correlation data, collaborative correction parameters are generated to obtain collaborative control analysis data.

[0054] Collaborative correction parameters (clearly defining the correction direction, magnitude, and priority, with severe anomalies being corrected first) will be used to analyze collaborative control data and synchronize it to the collaborative control process.

[0055] The working principle and technical effects of the above technical solution are as follows: The principle of this method is to analyze abnormal control feature data, analyze the impact of abnormalities and the derivative relationships between abnormalities, generate priority-based collaborative correction parameters, and realize the collaborative processing of multiple abnormalities. This solves the problems of existing technologies such as no correlation analysis of abnormalities, no basis for correction, and no priority, ensuring efficient and accurate abnormal correction. In specific implementation, the abnormal control feature data is first comprehensively analyzed to clarify the abnormality type, abnormality level (mild / severe), and location of occurrence, generating abnormal control analysis data. Based on the analysis data, the degree of impact of abnormalities on transdermal absorption, meridian and qi conduction, and user sensation is analyzed to determine the abnormal control impact data. Combined with the impact data, the derivative relationships between abnormalities are identified (such as positioning deviation leading to application abnormalities), generating abnormal control correlation data. Based on the correlation data, collaborative correction parameters are generated to clarify the correction direction, adjustment range, and priority (severe abnormalities are corrected first), obtaining collaborative control analysis data, which is synchronized to subsequent collaborative control links to ensure that abnormalities are corrected in a timely and accurate manner.

[0056] This method addresses the pain points of existing methods, such as lack of correlation analysis, lack of basis for correction, and lack of priority for anomalies; it improves the accuracy and efficiency of anomaly correction, avoids the generation and expansion of anomalies; reduces the risk of decreased treatment effect due to untimely or inaccurate anomaly handling; and optimizes collaborative control logic to reduce invalid equipment operations, thereby improving system operating efficiency and the stability of treatment effect.

[0057] In one embodiment of the present invention, S3 includes: Based on the targeted conditioning pathway and synergistic effect analysis data, operational parameter adjustment analysis and acupoint operation adjustment analysis were conducted to obtain operational parameter adjustment data and acupoint operation adjustment analysis data. The operation parameter adjustment data and acupoint operation adjustment analysis data are the control adjustment analysis data; Based on the control and regulation analysis data, the operating parameters are adjusted to obtain the operating parameter adjustment data; Adjust material usage based on operating parameter adjustment data to obtain material usage adjustment data; Adjust the acupoint operation based on the material usage adjustment data to obtain acupoint operation adjustment data; The system components are adjusted based on the acupoint operation data, thereby generating health conditioning and control data.

[0058] System component adjustments (including slow-release pen calibration and positioning auxiliary component debugging) will simultaneously transfer health conditioning and control adjustment data to S1 and S2 stages to form a closed-loop optimization.

[0059] The working principle and technical effect of the above technical solution are as follows: The principle of this method is to combine the targeted conditioning path and synergistic effect analysis data to carry out multi-dimensional adjustment analysis and dynamic adjustment, and construct a closed-loop optimization system for the whole process. This solves the problems of no dynamic adjustment, no closed loop and fixed parameters in the existing conditioning process, and ensures continuous optimization of conditioning effect. In practice, the process begins by analyzing the preset standards of the targeted treatment pathway and the synergistic effect analysis data. This involves performing separate operational parameter adjustment analysis and acupoint operation adjustment analysis to obtain operational parameter adjustment analysis data and acupoint operation adjustment analysis data. These two data points are then integrated to form the control and adjustment analysis data. Based on this data, operational parameters such as application speed and pressure are dynamically adjusted to obtain operational parameter adjustment data. Next, based on the operational parameter adjustment data, material usage parameters such as the release amount of the slow-release pen are adjusted to obtain material usage adjustment data. Finally, based on the material usage adjustment data, acupoint operation parameters such as acupoint location and pressure application method are adjusted to obtain acupoint operation adjustment data. Finally, based on the acupoint operation adjustment data, system components such as slow-release pen calibration and positioning auxiliary component debugging are adjusted to generate health conditioning control and adjustment data, which is then simultaneously fed back to stages S1 and S2, forming a closed-loop optimization process.

[0060] This method addresses the pain points of existing treatment processes, such as lack of dynamic adjustment, closed-loop system, and fixed parameters; it improves the adaptability of operating parameters, material usage, and acupoint operation to ensure continuous optimization of treatment effects; it reduces the risk of ineffective treatment and user discomfort caused by parameter mismatch; and it achieves closed-loop optimization of the entire process, further enhancing the intelligence and standardization of the technology and expanding its applicable scenarios.

[0061] In one embodiment of the present invention, the step of performing operational parameter adjustment analysis and acupoint operation adjustment analysis based on targeted conditioning pathways and synergistic effect analysis data to obtain operational parameter adjustment analysis data and acupoint operation adjustment analysis data includes: Based on the preset operating standards of the targeted conditioning path, the operation-related feedback of the synergistic effect analysis data is analyzed to obtain feedback analysis data, including synergistic effect data such as the release amount of the slow-release pen, the application speed, the pressure and time of the tap, abnormal feedback data, and user sensation feedback data. Based on the feedback analysis data, the deviation between the actual operating parameters and the preset standard is compared to determine the impact of the deviation and obtain the deviation impact determination information. The assessment of the impact of deviations includes whether the deviations affect the transdermal effect and whether they cause physical discomfort. Based on the deviation impact assessment data, determine the operating parameter adjustment scheme and generate operating parameter adjustment analysis data; The operating parameter adjustment plan includes specifying the adjustment range and the standard after adjustment; Based on the targeted conditioning pathway, relevant feedback data on acupoints are obtained, including the accuracy of acupoint location, the effect of acupoint connection, the synergistic effect of acupoint operation and transdermal absorption of active ingredients, and the impact of acupoint operation abnormalities (such as positioning deviation or reversed connection order) on the conditioning effect. Based on feedback data related to acupoints, determine the abnormal characteristics of acupoint operation and distinguish between location-related abnormalities and temporal abnormalities; Determine abnormal characteristics of acupoint manipulation based on feedback data related to acupoints; Determine acupoint positioning calibration data based on abnormal characteristics of acupoint manipulation; Acupoint location calibration data includes calibration methods and calibration thresholds; Based on the acupoint location calibration data, an acupoint adjustment plan is determined, and acupoint operation adjustment analysis data is generated.

[0062] The acupoint regulation scheme includes positioning deviation correction and series timing optimization. This data is fed back to the acupoint series link of S1 to achieve closed-loop correction.

[0063] The working principle and technical effect of the above technical solution are as follows: The principle of this method is based on the preset standard of the targeted conditioning path, analyzing feedback data, analyzing the deviation and impact of operation and acupoint operation, formulating a targeted adjustment plan, realizing the precise optimization of operation parameters and acupoint operation, and solving the problems of existing adjustment without basis and acupoint operation abnormalities that cannot be effectively corrected. In practice, the process begins by analyzing the operational feedback in the synergistic effect analysis data based on the preset operational standards of the targeted treatment path. This yields feedback analysis data (including synergistic effect data such as the release amount of the slow-release pen and the application speed, as well as abnormal feedback and sensory feedback). The deviations of the actual operational parameters from the preset standards are compared to determine whether the deviations affect the transdermal effect or cause sensory discomfort, thus obtaining deviation impact assessment information. Based on this assessment information, a clear adjustment range and a post-adjustment standard operational parameter adjustment plan are developed, generating operational parameter adjustment analysis data. Simultaneously, acupoint-related feedback data is acquired, analyzing acupoint positioning accuracy and serial connection effects, distinguishing between positioning-related and temporal-related anomalies, and identifying acupoint operation anomaly characteristics. Based on these anomaly characteristics, acupoint positioning calibration data including calibration methods and calibration thresholds is determined. An acupoint adjustment plan for positioning deviation correction and serial temporal optimization is developed, generating acupoint operation adjustment analysis data, which is then fed back to the S1 acupoint serial connection link to achieve closed-loop correction.

[0064] This method addresses the pain points of existing treatments lacking a basis and failing to effectively correct acupoint manipulation abnormalities; it improves the accuracy of operating parameters and acupoint manipulation, optimizes transdermal effects and the efficiency of Qi conduction; it reduces the risk of poor treatment results due to operational deviations and acupoint manipulation abnormalities; and it simultaneously achieves closed-loop correction of acupoint manipulation abnormalities, further enhancing the stability and accuracy of multi-acupoint synergistic treatment.

[0065] According to one embodiment of the present invention, the system includes: The path generation module is used to acquire preset key acupoint information, perform key acupoint chain analysis based on the preset key acupoint information, obtain acupoint chain analysis data, and generate a targeted conditioning path based on the acupoint chain analysis data. The synergistic effect module is used to perform synergistic control based on the targeted conditioning path, obtain synergistic control data, and perform synergistic effect analysis based on the synergistic control data to obtain synergistic effect analysis data. The control and regulation module is used to perform control and regulation analysis based on the targeted conditioning path and synergistic effect analysis data, obtain control and regulation analysis data, and then perform health conditioning control and regulation based on the control and regulation analysis data to obtain health conditioning control and regulation data.

[0066] The working principle and technical effects of the above-mentioned technical solution are as follows: This method achieves targeted and precise conditioning by accurately connecting acupoints, synergistically controlling drug delivery, and dynamically adjusting parameters, breaking through the bottlenecks of traditional conditioning based on experience and non-targeted transdermal drug delivery. In specific implementation, the information of preset key acupoints (including coordinates, meridian affiliation, etc.) is first entered into the system. Based on the meridian and qi conduction law, the rationality of acupoint connection is analyzed, the optimal connection sequence and connection interval are calculated, and acupoint connection analysis data is generated and integrated into a targeted conditioning path. Then, the sustained-release pen, positioning component and other devices are controlled to synergistically perform acupoint application and acupressure operations, and the application dosage, acupressure intensity and other synergistic control data are collected in real time. Then, combined with transdermal effect and somatosensory feedback analysis data, it is judged whether the synergistic effect meets the standard, and synergistic effect analysis data is generated. Finally, the target path is compared with the preset standard, the operation deviation is analyzed, the adjustment direction and amplitude are determined, the operation parameters and material usage are dynamically adjusted, health conditioning control and adjustment data are generated and fed back to the previous stage to form a closed-loop optimization.

[0067] This method addresses the pain points of traditional treatments, such as lack of standards, poor transdermal targeting, and lack of closed-loop optimization; it improves the accuracy of acupoint positioning, the stability of treatment, and the level of standardization, reducing reliance on professionals; it reduces the probability of ineffective treatment, the risk of skin irritation, and human error, and lowers the difficulty of technical implementation; at the same time, it enables the treatment process to be traceable and reproducible, further enhancing the industrial application value of the technology.

[0068] Obviously, those skilled in the art can make various modifications and variations to this invention without departing from its spirit and scope. Therefore, if these modifications and variations fall within the scope of the claims of this invention and their equivalents, this invention also intends to include these modifications and variations.

Claims

1. A health conditioning method based on meridian acupoint targeted transdermal drug delivery, characterized in that, The method includes: S1. Obtain preset key acupoint information, perform key acupoint series analysis based on preset key acupoint information, obtain acupoint series analysis data, and generate targeted conditioning path based on the acupoint series analysis data. S2. Perform synergistic control based on the targeted conditioning pathway, obtain synergistic control data, and perform synergistic effect analysis based on the synergistic control data to obtain synergistic effect analysis data; S3. Based on the targeted conditioning pathway and synergistic effect analysis data, control and regulation analysis is performed to obtain control and regulation analysis data. Based on the control and regulation analysis data, health conditioning and control are performed to obtain health conditioning and control data.

2. The health conditioning method based on meridian acupoint targeted transdermal drug delivery according to claim 1, characterized in that, S1 includes: Acquire preset facial acupoint information, acupoint information on both sides of the nose, acupoint information around the ears, and acupoint information at the back of the neck; Based on preset facial acupoint information, acupoint information on both sides of the nose, acupoint information around the ears, and acupoint information at the back of the neck, determine the information along the facial meridians, the information along the meridians on both sides of the nose, the information along the meridians around the ears, and the information along the acupoints at the back of the neck. A pre-defined active ingredient composition and a sustained-release pen are obtained. The pre-defined active ingredient composition is stored and quantitatively released using the sustained-release pen, and sustained-release pen application data are obtained. According to the preset sequence of connection, the information along the facial meridians, the information along the meridians on both sides of the nose, the information along the meridians around the ears, and the information along the acupoints at the back of the neck are connected to obtain acupoint connection data. By using acupoint data to perform coordinated application of the slow-release pen, coordinated application data is obtained. Targeted treatment pathways were determined based on data from synergistic application.

3. The health conditioning method based on meridian acupoint targeted transdermal drug delivery according to claim 2, characterized in that, The process involves connecting facial meridian information, meridian information on both sides of the nose, meridian information around the ears, and acupoint information at the back of the neck according to a preset sequence to obtain acupoint connection data, including: Obtain acupoint location information, and determine the acupoint location information along the acupoint line based on the acupoint line information and the acupoint location information; The location information of acupoints along the line is connected according to a preset connection sequence to obtain the location connection information; Perform location anomaly identification on the location serialization information to obtain location anomaly identification information; Based on the location anomaly identification information, determine the anomaly identification information along the acupoint line; Matching and determining information is performed based on abnormal identification information along the acupoints; The acupoint location is corrected based on the matching judgment information until there is no abnormal location identification information, and acupoint serialization data is generated.

4. The health conditioning method based on meridian acupoint targeted transdermal drug delivery according to claim 2, characterized in that, The method of obtaining coordinated application data for the sustained-release pen by connecting acupoint data includes: Serial feature extraction is performed on the serial acupoint data to obtain serial feature extracted data; Preliminary smearing parameters are generated by extracting data based on concatenated features. Based on the initial application parameters, perform acupressure massage to obtain acupressure massage data; By integrating the initial application parameters with the acupressure massage data, synergistic application data is obtained.

5. The health conditioning method based on meridian acupoint targeted transdermal drug delivery according to claim 1, characterized in that, S2 includes: Material control parameters are determined by targeting the conditioning path, and application control data is obtained by applying the material control parameters to the targeted conditioning path. Based on the application control data, an application control analysis is performed to obtain application control analysis data; Based on the smear control analysis data, abnormal control characteristics are determined, and abnormal control characteristic data are obtained. Based on the abnormal control characteristic data, collaborative control analysis is performed to obtain collaborative control analysis data; Based on the collaborative control analysis data, collaborative control is performed to obtain collaborative effect data; The status of the synergistic effect data is determined to obtain synergistic effect analysis data.

6. The health conditioning method based on meridian acupoint targeted transdermal drug delivery according to claim 5, characterized in that, The step of performing application control analysis based on application control data to obtain application control analysis data includes: Preliminary application parameters and actual application parameters are obtained based on the application control data; The preliminary application parameters are compared with the actual application parameters to obtain application comparison parameters; Based on the smearing comparison parameters, determine the smearing anomaly characteristics and obtain smearing anomaly characteristic data; Based on the abnormal smearing feature data, the abnormal smearing control data is determined, and then the smearing control analysis data is obtained.

7. The health conditioning method based on meridian acupoint targeted transdermal drug delivery according to claim 5, characterized in that, The step of performing collaborative control analysis based on abnormal control feature data to obtain collaborative control analysis data includes: The anomaly control feature data is parsed to obtain anomaly control parsing data; Determine the impact data of abnormal control based on the abnormal control analysis data; Correlate the abnormal control analysis data with the abnormal control impact data to obtain abnormal control correlation data; Based on the abnormal control correlation data, collaborative correction parameters are generated to obtain collaborative control analysis data.

8. The health conditioning method based on meridian acupoint targeted transdermal drug delivery according to claim 1, characterized in that, S3 includes: Based on the targeted conditioning pathway and synergistic effect analysis data, operational parameter adjustment analysis and acupoint operation adjustment analysis were conducted to obtain operational parameter adjustment data and acupoint operation adjustment analysis data. The operation parameter adjustment data and acupoint operation adjustment analysis data are the control adjustment analysis data; Based on the control and regulation analysis data, the operating parameters are adjusted to obtain the operating parameter adjustment data; Adjust material usage based on operating parameter adjustment data to obtain material usage adjustment data; Adjust the acupoint operation based on the material usage adjustment data to obtain acupoint operation adjustment data; The system components are adjusted based on the acupoint operation data, thereby generating health conditioning and control data.

9. A health conditioning method based on meridian acupoint targeted transdermal drug delivery according to claim 8, characterized in that, The process involves adjusting operational parameters and acupoints based on targeted conditioning pathways and synergistic effect analysis data to obtain operational parameter adjustment analysis data and acupoint adjustment analysis data, including: Based on the preset operating standards of the targeted conditioning pathway, the operation-related feedback of the synergistic effect analysis data is analyzed to obtain feedback analysis data; Based on the feedback analysis data, the deviation between the actual operating parameters and the preset standard is compared to determine the impact of the deviation and obtain the deviation impact determination information. Based on the deviation impact assessment data, determine the operating parameter adjustment scheme and generate operating parameter adjustment analysis data; Obtain feedback data related to acupoints based on the targeted treatment pathway; Determine abnormal characteristics of acupoint manipulation based on feedback data related to acupoints; Determine acupoint positioning calibration data based on abnormal characteristics of acupoint manipulation; Based on the acupoint location calibration data, an acupoint adjustment plan is determined, and acupoint operation adjustment analysis data is generated.

10. A health conditioning system based on meridian acupoint targeted transdermal drug delivery, characterized in that, The system includes: The path generation module is used to acquire preset key acupoint information, perform key acupoint chain analysis based on the preset key acupoint information, obtain acupoint chain analysis data, and generate a targeted conditioning path based on the acupoint chain analysis data. The synergistic effect module is used to perform synergistic control based on the targeted conditioning path, obtain synergistic control data, and perform synergistic effect analysis based on the synergistic control data to obtain synergistic effect analysis data. The control and regulation module is used to perform control and regulation analysis based on the targeted conditioning path and synergistic effect analysis data, obtain control and regulation analysis data, and then perform health conditioning control and regulation based on the control and regulation analysis data to obtain health conditioning control and regulation data.

Images